You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國邦醫藥(605507.SH):一季度中間體硼氫化鈉銷售利好消失對盈利有所影響
格隆匯 04-18 16:27

格隆匯4月18日丨有投資者向國邦醫藥(605507.SH)提問:2023年一季度營業收入同比增長19.90%,淨利潤同比下降-2.88%,具體原因?

國邦醫藥回覆:2023一季度公司在重點項目帶動戰略下,各版塊業務依然保持強勁增長,尤其是動保板塊在景氣度較低的背景下,出貨量依然取得明顯增長。由於去年一季度關鍵醫藥中間體硼氫化鈉受新冠藥物影響銷售較好,本期這塊偶然因素消失對盈利有所影響,同時一季度匯兑損益也有部分影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account